BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12021166)

  • 1. Perspective: prostate cancer susceptibility genes.
    Simard J; Dumont M; Soucy P; Labrie F
    Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer susceptibility genes: lessons learned and challenges posed.
    Simard J; Dumont M; Labuda D; Sinnett D; Meloche C; El-Alfy M; Berger L; Lees E; Labrie F; Tavtigian SV
    Endocr Relat Cancer; 2003 Jun; 10(2):225-59. PubMed ID: 12790786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
    Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
    Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
    Cunningham JM; McDonnell SK; Marks A; Hebbring S; Anderson SA; Peterson BJ; Slager S; French A; Blute ML; Schaid DJ; Thibodeau SN;
    Prostate; 2003 Dec; 57(4):335-46. PubMed ID: 14601030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A candidate prostate cancer susceptibility gene at chromosome 17p.
    Tavtigian SV; Simard J; Teng DH; Abtin V; Baumgard M; Beck A; Camp NJ; Carillo AR; Chen Y; Dayananth P; Desrochers M; Dumont M; Farnham JM; Frank D; Frye C; Ghaffari S; Gupte JS; Hu R; Iliev D; Janecki T; Kort EN; Laity KE; Leavitt A; Leblanc G; McArthur-Morrison J; Pederson A; Penn B; Peterson KT; Reid JE; Richards S; Schroeder M; Smith R; Snyder SC; Swedlund B; Swensen J; Thomas A; Tranchant M; Woodland AM; Labrie F; Skolnick MH; Neuhausen S; Rommens J; Cannon-Albright LA
    Nat Genet; 2001 Feb; 27(2):172-80. PubMed ID: 11175785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complex genetic epidemiology of prostate cancer.
    Schaid DJ
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R103-21. PubMed ID: 14749351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
    Nupponen NN; Wallén MJ; Ponciano D; Robbins CM; Tammela TL; Vessella RL; Carpten JD; Visakorpi T
    Genes Chromosomes Cancer; 2004 Feb; 39(2):119-25. PubMed ID: 14695991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.
    Carpten J; Nupponen N; Isaacs S; Sood R; Robbins C; Xu J; Faruque M; Moses T; Ewing C; Gillanders E; Hu P; Bujnovszky P; Makalowska I; Baffoe-Bonnie A; Faith D; Smith J; Stephan D; Wiley K; Brownstein M; Gildea D; Kelly B; Jenkins R; Hostetter G; Matikainen M; Schleutker J; Klinger K; Connors T; Xiang Y; Wang Z; De Marzo A; Papadopoulos N; Kallioniemi OP; Burk R; Meyers D; Grönberg H; Meltzer P; Silverman R; Bailey-Wilson J; Walsh P; Isaacs W; Trent J
    Nat Genet; 2002 Feb; 30(2):181-4. PubMed ID: 11799394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for familial and hereditary prostate cancer.
    Lynch HT; Kosoko-Lasaki O; Leslie SW; Rendell M; Shaw T; Snyder C; D'Amico AV; Buxbaum S; Isaacs WB; Loeb S; Moul JW; Powell I
    Int J Cancer; 2016 Jun; 138(11):2579-91. PubMed ID: 26638190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 and BRCA2 have a limited role in familial prostate cancer.
    Sinclair CS; Berry R; Schaid D; Thibodeau SN; Couch FJ
    Cancer Res; 2000 Mar; 60(5):1371-5. PubMed ID: 10728701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic susceptibility to prostate cancer].
    Cussenot O; Cancel-Tassin G
    Med Sci (Paris); 2004 May; 20(5):562-8. PubMed ID: 15190476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
    Wu YQ; Chen H; Rubin MA; Wojno KJ; Cooney KA
    Cancer Res; 2001 Dec; 61(24):8651-3. PubMed ID: 11751379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the RNAse L gene in prostate cancer.
    Kieffer N; Schmitz M; Scheiden R; Nathan M; Faber JC
    Bull Soc Sci Med Grand Duche Luxemb; 2006; (1):21-8. PubMed ID: 16869093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients.
    Orr-Urtreger A; Bar-Shira A; Bercovich D; Matarasso N; Rozovsky U; Rosner S; Soloviov S; Rennert G; Kadouri L; Hubert A; Rennert H; Matzkin H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):474-9. PubMed ID: 16537704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
    Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci.
    Goode EL; Stanford JL; Peters MA; Janer M; Gibbs M; Kolb S; Badzioch MD; Hood L; Ostrander EA; Jarvik GP
    Clin Cancer Res; 2001 Sep; 7(9):2739-49. PubMed ID: 11555587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
    Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi OP
    Clin Cancer Res; 2000 Dec; 6(12):4810-5. PubMed ID: 11156239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1.
    Lange EM; Gillanders EM; Davis CC; Brown WM; Campbell JK; Jones M; Gildea D; Riedesel E; Albertus J; Freas-Lutz D; Markey C; Giri V; Dimmer JB; Montie JE; Trent JM; Cooney KA
    Prostate; 2003 Dec; 57(4):326-34. PubMed ID: 14601029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.